Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NGM438 |
Trade Name | |
Synonyms | NGM-438|NGM 438 |
Drug Descriptions |
NGM438 is a monoclonal anti-LAIR1 antibody that blocks collagen-induced immune suppression, which potentially leads to increased sensitivity to immune checkpoint inhibitors (Cancer Res 2022;82(12_Suppl):Abstract nr LB219). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187128 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NGM438 | NGM438 | 0 | 1 |
NGM438 + Pembrolizumab | NGM438 Pembrolizumab | 0 | 1 |